Skip to content

Return to Work and Living Healthy After Head and Neck Cancer

Return to Work and Living Healthy After Head and Neck Cancer

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03065634
Acronym
RELIANCE
Enrollment
39
Registered
2017-02-28
Start date
2017-01-01
Completion date
2018-12-31
Last updated
2020-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Brief summary

Based on a randomized controlled trial, the manualized group intervention Return to work and living healthy after head and neck cancer (RELIANCE) for head and neck cancer survivors will be tested against a non-manualized control intervention (social counseling) in order to evaluate the efficacy of the RELIANCE intervention compared to the control condition. The study design includes two phases, the initial study phase (pilot study) and the intervention study (RCT). The aim of the pilot study is to implement and ensure the necessary standardized procedures for the implementation of patient recruitment and interventions. In the randomized controlled trial, potential participants are assigned to the intervention group or to the control group.

Interventions

BEHAVIORALReturn to work and living healthy after head and neck cancer

Return to work and living healthy after head and neck cancer (RELIANCE) is a 2-months group intervention for head and neck cancer patients delivered by a trained psychotherapist and a peer in eight sessions. The individual sessions aim to improve work ability, quality of life and psychological well-being

BEHAVIORALsocio-legal counseling

Non-manualized socio-legal counseling two socio-legal counseling sessions delivered by a social worker

Sponsors

Universitätsklinikum Leipzig
CollaboratorOTHER
Jena University Hospital
CollaboratorOTHER
Klinikum St. Georg gGmbH
CollaboratorOTHER
Stadtisches Klinikum Dresden
CollaboratorOTHER
German Cancer Aid
CollaboratorOTHER
University of Leipzig
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Open Label

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of laryngea, hypopharyngeal, oropharyngeal, tonsil or base of the tongue cancer within the last six months * Curative treatment * Completion of primary and follow-up Treatment * Fluency in German * Written informed and voluntary consent * Psychological distress (Distress Thermometer score \> 4) * Self-perceived prognosis of employment (SPE score ≥ 1)

Exclusion criteria

* Alcohol dependency with physical withdrawal symptoms (CAGE score ≥ 3 and current use of alcohol) * Acute suicidal tendencies * Receiving old-age pension or will receive old-age pension within the next 12 months * Cognitive impairment indicated in the medical records or by the attending doctor * Being in psychotherapy

Design outcomes

Primary

MeasureTime frameDescription
Work abilitydirectly after intervention and at six months follow-upWork-Ability-Index, short version (WAI)
Pattern of work-related coping behaviourdirectly after intervention and at six months follow-upPattern of work-related coping behaviour, short Version (AVEM-44)

Secondary

MeasureTime frameDescription
anxiety, depression and psychological distress in patients with somatic diseasesdirectly after intervention and at six months follow-upHospital Anxiety and Depression Scale (HADS)
Cancer-specific health-related quality of Life (global, functioning, symptom burden)directly after intervention and at six months follow-upQuality of Life Core Questionnaire of the European Organisation for Research and Treatment of Cancer (EORTC-QLQ-C30)
general self-efficacy expectationdirectly after intervention and at six months follow-upgeneral self-efficacy expectation (ASKU)
health behavior and health related attitudes and knowledge about specific diseasesdirectly after intervention and at six months follow-upquestionnaire measuring health behavior and health related attitudes and knowledge about specific diseases (FEG)
Quality of life and symptoms specific to head and neck cancerdirectly after intervention and at six months follow-upHead and Neck Module of the European Organisation for Research and Treatment of Cancer (EORTC-H&N35)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026